Company Overview
About Fulcrum Therapeutics
Fulcrum Therapeutics is a United States-based company focused on modulating gene expression to treat the root cause of genetically defined diseases. The company's lead program, pociredir, is being investigated in clinical trials to treat sickle cell disease, a condition with high unmet medical need. Fulcrum Therapeutics is committed to improving the lives of patients with genetically defined diseases.